State Stem Cell Agency ICOC Intellectual Property Task Force Subcommittee Agenda 11/22/05

Return to CIRM Meetings and Events

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

 

Regular Meeting 11-22-05

IP TASK FORCE SUBCOMMITTEE
OF THE INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 
 

OPEN SESSION

  1. Call to Order.
  2. Roll Call.
  3. Informational presentations:
    1. APA regulations as they relate to a CIRM IP policy
    2. Tax-exempt and taxable bonds as they relate to a CIRM IP policy
    3. Alternative” models for IP policies and how they relate to a CIRM IP policy
    4. Discussion of Nov. 17, 2005 NRC report: “Intellectual Property Rights in Genomic and Proteomic Research: Access to Discoveries, Inventors’ Rights, and Public Health” and any recommendations relevant for CIRM’s IP policy
  4. Public Comment.
  5. Consideration of process for developing Interim IP Policy for CIRM Training Grants.
  6. Public Comment.
  7. Consideration of next Task Force meeting.
  8. Adjournment.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 

Transcripts


Date Published: April 6, 2009
Last Modified: April 5, 2017